The plant's products will fully cover the needs of the population of Uzbekistan for blood products at the level of world standards of treatment and create export potential

A large freezer warehouse with constant temperature monitoring will be built to store raw materials used to make blood products - human plasma for fractionation.

Medicines obtained from donor human blood plasma are in demand in almost all branches of medicine. Blood products (albumin, immunoglobulin, coagulation factors) are used in the treatment of oncological, hematological, autoimmune, orphan and other serious diseases.

Albumin is available in 5, 10 and 20% solutions. Albumin is indicated for various types of shock - traumatic, surgical, burn, as well as for edema caused by disorders of the protein composition of the blood, with disorders of albumin synthesis in the liver and its large loss (for example, with cirrhosis of the liver, ascites, burns). Plasma immunoglobulins have specific activity against infectious diseases. In clinical practice, normal human immunoglobulin is most widely used. The use of immunoglobulins is indicated for patients with chronic lymphocytic leukemia, hepatitis A and B, organ and bone marrow transplantation, HIV infection in children, multiple myeloma, chronic diseases of connective and nervous tissues, idiopathic thrombocytopenic purpura. Hemostatic drugs include cryoprecipitate, prothrombin complex, fibrinogen, coagulation factors (FVII, FIX), which are used to treat patients with hemophilia, liver disease, and massive bleeding.